China (Mainland)
Tofacitinib Citrate N-1 CAS NO.477600-74-1
- FOB Price: USD: /Kilogram Get Latest Price
- Min.Order: 100 Kilogram
- Payment Terms: L/C,T/T
- Available Specifications:
Pharma Grade(5-10)KilogramPharma Grade(10-100)Kilogram
- Product Details
Keywords
- N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- Rheumatoid arthritis drugs
- Tofacitnib manufacture
Quick Details
- ProName: Tofacitinib Citrate N-1
- CasNo: 477600-74-1
- Molecular Formula: C13H19N5
- Appearance: White powder
- Application: Used as APIs for Parkinson
- DeliveryTime: 1000kgs prompt shipment
- PackAge: 25kgs per package
- Port: Shanghai,China
- ProductionCapacity: 10 Kilogram/Day
- Purity: nlt hplc 99%
- Storage: Stored in cool shadow place
- Transportation: Normal conditions
- LimitNum: 100 Kilogram
- Related Substances: Total impurity: nmt 0.5%, single impur...
- Residue on Ignition: not more than 0.50%
- Heavy Metal: not more than 50 ppm
- Valid Period: Within 2 years
- Impurity A not more than 0.15 %: N.D
- Water：not more than 0.50%: 0.20
- Heavy metal: not more than 20 ppm: 10
- TYMC not more than 1000 cfu/g: Conforms
- TAMC not more than 100 cfu/g: Conforms
- Assay: 98.0%-- 102.0%: 99.60%
Superiority
Anhui Ailead Pharmaceutical Co.Ltd
Founded in Oct. 2019 and located in Anqing New High-tech.zone of Anhui province,it’s mainly engaged in the R&D、production and marketing of advanced-intermediates、APIs and drugs.
It is designed and constructed conforming to FDA and GMP standards to guarantee the manufacturing site to be environmental protection
About US
1 Set up in national chemical industry park with an land area of 48000㎡and Gross floor area of 40000㎡.
2 The APIs & intermediates manufacturing site covers an area of 15000 square meters, the reactors can be available for specific reactions including high temperature、high pressure、cryogenic and hydrogenation reactions
3 The project part I are equipped with 61 reactors with an volume from 50-5000L and total volume of 75.75 m³, 2 set of reactors can be available for Cryogenic reactions with temp.from -100~-30 degrees and in reactors 1500L and 3000L each,5 sets of reactors (6.0mpa 5.0mpa 2.5mpa)can be available for high pressure actions.
4 The drugs workshop covers an area of over 11000 ㎡,it will be used to produce oral solid drugs、topical drugs and other dosages.
5 The manufacturing site is designed and constructed conforming to GMP and FDA standards
6 The DCS control system(designed by Zhejiang University) and the TCU temperature control system are adopted
7 It has a waste water treatment capacity of 300 mt per day.
Details
Alicorn Pharmaceutical Co.,Ltd is a national high-tech enterprise engaged in the R&D and manufacturing of new drugs、modified new drugs、generic drugs and pharmaceutical intermediates.It has 3 subsidiaries,Jiangsu Alicorn Pharmaceutical Technology Co., Ltd、Zhejiang Alicorn New-drug R&D Co.,Ltd and Anhui Ailead Pharmaceutical Co., Ltd.
Jiangsu Alicorn Pharmaceutical Technology Co., Ltd is located in Nanjing Jiangsu province,mainly dedicated to the R&D of modified new drugs、generic drugs and APIs.Zhejiang Alicorn New-drug R&D Co.,Ltd is located in Jiaxing Zhejiang province,engaged in the R&D and discovery of new drugs and molecules.
With an area of 72mu in Anqing Anhui province,Anhui Ailead Pharmaceutical Co., Ltd is used for the commercial production of the intermediates、APIs and drugs.
Our business scope
R&D and registration
Research and development of generic drugs
Research and development of new drugs
Conformance evaluation of generic drugs
Process optimization and changes of APIs and drugs
Patent strategic consulting
Application and registration consulting
Technical service and consulting
Customization and production
New molecular compound customized synthesis
Pharmaceutical intermediates customized manufacturing
APIs customized manufacturing
APIs and drugs joint development
APIs contract manufacturing
Drugs contract manufacturing
Jiangsu Alicorn Pharmaceutical Technology Co., Ltd
It covers an area of 1800 square meters,mainly dedicated to the process development and optimization of APIs 、pharmaceutical intermediates、solid & liquid drugs and quality & stability research.
Zhejiang Alicorn New-drug R&D Co.,Ltd
It covers an area of over 3500 square meters,mainly participated in the customization and synthesis of new molecular compound.
Anqing Technical center ( under construction)
The lab has an area of 1200 square meters,mainly used for the process optimization、finalization、scale-up and costing control of APIs and pharmaceutical intermediates.
Anhui Ailead Pharmaceutical Co.Ltd
Founded in Oct. 2019 and located in Anqing New High-tech.zone of Anhui province,it’s mainly engaged in the R&D、production and marketing of advanced-intermediates、APIs and drugs.
It is designed and constructed conforming to FDA and GMP standards to guarantee the manufacturing site to be environmental protection
About US
1 Set up in national chemical industry park with an land area of 48000㎡and Gross floor area of 40000㎡.
2 The APIs & intermediates manufacturing site covers an area of 15000 square meters, the reactors can be available for specific reactions including high temperature、high pressure、cryogenic and hydrogenation reactions
3 The project part I are equipped with 61 reactors with an volume from 50-5000L and total volume of 75.75 m³, 2 set of reactors can be available for Cryogenic reactions with temp.from -100~-30 degrees and in reactors 1500L and 3000L each,5 sets of reactors (6.0mpa 5.0mpa 2.5mpa)can be available for high pressure actions.
4 The drugs workshop covers an area of over 11000 ㎡,it will be used to produce oral solid drugs、topical drugs and other dosages.
5 The manufacturing site is designed and constructed conforming to GMP and FDA standards
6 The DCS control system(designed by Zhejiang University) and the TCU temperature control system are adopted
7 It has a waste water treatment capacity of 300 mt per day.